Richard Evan Gelinas

Title: Richard Evan Gelinas: Innovator in Antibody Therapeutics

Introduction

Richard Evan Gelinas is a prominent inventor based in Seattle, WA (US), known for his significant contributions to the field of antibody therapeutics. With a total of 7 patents, Gelinas has focused on developing methods for treating diseases mediated by interleukin-6 (IL-6), a cytokine involved in inflammation and immune response.

Latest Patents

Among his latest patents, Gelinas has developed methods for treating IL-6 mediated diseases with antibody molecules specific for IL-6. This invention relates to antibody molecules that have specificity for antigenic determinants of IL-6, along with their therapeutic uses and methods for producing these antibody molecules. Another notable patent involves methods for making antibody molecules that specifically target human IL-6, further emphasizing his commitment to advancing therapeutic options for patients.

Career Highlights

Throughout his career, Gelinas has worked with reputable organizations such as UCB Pharma and Fred Hutchinson Cancer Center. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in antibody therapies.

Collaborations

Some of his notable coworkers include Mitra Choudhury Singhal and Yi Lin Zhang, who have played significant roles in his research endeavors.

Conclusion

Richard Evan Gelinas continues to be a key figure in the development of innovative antibody therapies, with a focus on addressing IL-6 mediated diseases. His contributions to the field are invaluable and highlight the importance of ongoing research in therapeutic advancements.